EUVIMED · CrossrefZeitschrift
Frontiers in Nuclear Medicine
ISSN 2673-8880 · Frontiers Media SA
Neueste Artikel
Refining risk assessment in 177Lu-DOTATATE extravasation: the value of 3D Monte Carlo dosimetry
Radiopharmaceutical therapy in cancer: clinical momentum, biological complexity, and the next era of precision systemic radiation oncology
Automated cassette-based production, purification, and radiolabeling of [89Zr]Zr-DFO-trastuzumab
Editorial: Total body positron emission tomography: science and clinical applications
Improved random coincidence estimation including triple coincidence detection in PET
Pittsburgh compound B positron emission tomography detects cardiomyopathy in hereditary transthyretin amyloidosis patients with negative bone scintigraphy: a pilot study
Recent clinical advances in fibroblast activation protein targeted radioligand therapy for solid tumors
Targeted radionuclide therapy and diagnostic imaging of SSTR positive neuroendocrine tumors: a clinical update in the new decade
αvβ6-integrin targeted PET/CT imaging in pancreatic cancer patients using 68Ga-Trivehexin
Ionising radiation exposure-induced regulation of selected biomarkers and their impact in cancer and treatment
QUALIPAED—A retrospective quality control study evaluating pediatric long axial field-of-view low-dose FDG-PET/CT
Advances and challenges in immunoPET methodology
An assessment of PET and CMR radiomic features for the detection of cardiac sarcoidosis
The application of radionuclide therapy for breast cancer
Mini review of first-in-human integrin αvβ6 PET tracers
Evaluation of deep space exploration risks and mitigations against radiation and microgravity
Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer
Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease
Integration of advanced 3D SPECT modelling for pinhole collimators into the open-source STIR framework
Case report: Efficacy of lutetium-177 oxodotreotide for neuroendocrine tumor with central nervous system metastases
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles
18F-FDG PET/CT Imaging: Normal Variants, Pitfalls, and Artifacts Musculoskeletal, Infection, and Inflammation
18F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review
PET and SPECT Specialty Grand Challenge. When Knowledge Travels at the Speed of Light, Photons Take to the Field
Bone Scintigraphy of Vertebral Fractures With a Whole-Body CZT Camera in a PET-Like Utilization
Radiosynthesis of [11C]Ibrutinib via Pd-Mediated [11C]CO Carbonylation: Preliminary PET Imaging in Experimental Autoimmune Encephalomyelitis Mice
Fully Automated 68Ga-Labeling and Purification of Macroaggregated Albumin Particles for Lung Perfusion PET Imaging
Case Report: Pleuropulmonary Blastoma in a 2.5-Year-Old Boy: 18F-FDG PET/CT Findings
Clinical Outcomes After Radioiodine Therapy, According to the Method of Preparation by Recombinant TSH vs. Endogenous Hypothyroidism, in Thyroid Cancer Patients at Intermediate-High Risk of Recurrence
Amino Acid and Proliferation PET/CT for the Diagnosis of Multiple Myeloma
EUVIMED